SCOPUS 정보 검색 플랫폼

Drug Discovery World

Volumn 10, Issue 4, 2009, Pages 27-31

Predictive tests and personalised medicine

(1) Blair, Eddie a,b,c

a Integrated Medicines Ltd (United Kingdom)

b IDS Holdings Plc

c UNIVERSITY OF CAMBRIDGE (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; CETUXIMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; PANITUMUMAB; UNCLASSIFIED DRUG; ZAIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC PROCEDURE; DRESS SYNDROME; DRUG EFFICACY; DRUG SAFETY; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICINE; PATIENT SAFETY; PREDICTION; PREDICTIVE VALIDITY; PROGNOSIS; TREATMENT RESPONSE;

EID: 70350629002 PISSN: 14694344 EISSN: None Source Type: Journal
DOI: None Document Type: Article

Times cited : (13)

References (8)

1
- 0034844646
- Clinical application of pharmacogenetics
- Spear, BB, Heath-Chiozzi, M, Huff, J. Clinical application of pharmacogenetics. Trends Mol Med. (2001) 7(5): 201-204.
- (2001) Trends Mol Med , vol.7 , Issue.5 , pp. 201-204
- Spear, B.B.¹ Heath-Chiozzi, M.² Huff, J.³

2
- 36749080921
- Novel risk-sharing scheme puts the spotlight on biomarkers
- DOI 10.1038/nrd2478, PII NRD2478
- Hughes, B. Novel risk-sharing scheme puts the spotlight on biomarkers. Nature Reviews Drug Discovery (2007) 6: 945. (Pubitemid 350201782)
- (2007) Nature Reviews Drug Discovery , vol.6 , Issue.12 , pp. 945
- Hughes, B.¹

3
- 33947712686
- Stratified medicine: Strategic and economic implications of combining drugs and clinical biomarkers
- Trusheim, MR, Berndt, ER, Douglas, FL. Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nature Reviews Drug Discovery (2007) 6: 287-293.
- (2007) Nature Reviews Drug Discovery , vol.6 , pp. 287-293
- Trusheim, M.R.¹ Berndt, E.R.² Douglas, F.L.³

4
- 33947196825
- Impact of a 21-Gene RT-PCR Assay on Treatment Decisions in Early-Stage Breast Cancer
- Lyman, GH, Cosler, LE, Kuderer, NM, Hornberger, J. Impact of a 21-Gene RT-PCR Assay on Treatment Decisions in Early-Stage Breast Cancer. CANCER (2007) 109 (6): 1011-1018.
- (2007) Cancer , vol.109 , Issue.6 , pp. 1011-1018
- Lyman, G.H.¹ Cosler, L.E.² Kuderer, N.M.³ Hornberger, J.⁴

5
- 43449094338
- Is personalized medicine finally arriving?
- Allison, M. Is personalized medicine finally arriving? Nature Biotechnology (2008) 26 (5): 509-517.
- (2008) Nature Biotechnology , vol.26 , Issue.5 , pp. 509-517
- Allison, M.¹

6
- 54949085398
- K-ras mutations and benefit from cetuximab in advanced colorectal cancer
- Karapetis, CS, Khambata-Ford, S, Jonker, DJ et al. K-ras mutations and benefit from cetuximab in advanced colorectal cancer. NEJM (2008) 359: 1757-1765.
- (2008) NEJM , vol.359 , pp. 1757-1765
- Karapetis, C.S.¹ Khambata-Ford, S.² Jonker, D.J.³

7
- 52149112915
- Pharmacogenetics of hypersensitivity to abacavir: From PGx hypothesis to confirmation to clinical utility
- Hughes, AR, Spreen, WR, Mosteller, M et al. Pharmacogenetics of hypersensitivity to abacavir: from PGx hypothesis to confirmation to clinical utility. Pharma-cogenomics Journal (2008) 8: 365-374.
- (2008) Pharma-cogenomics Journal , vol.8 , pp. 365-374
- Hughes, A.R.¹ Spreen, W.R.² Mosteller, M.³

8
- 58149462603
- Macmillan Press. ISBN 978-0-230-51757-8
- Brown, G. The Living End: the future of death, aging and immortality. (2008). Macmillan Press. ISBN 978-0-230-51757-8.
- (2008) The Living End: the Future of Death, Aging and Immortality
- Brown, G.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.